A look back on London EdTech Week 2024; exclusive insights from Gold Sponsor, Goodnotes, & Silver Sponsor, Datasite; and IBIS Capital Analyst, Sophia Nasser, considers if GLP-1 agonists are a miracle cure in tackling global obesity.
Plus, market roundups & industry analyses across EdTech & HealthTech.
Read the July 2024 edition here
In this issue: Tech-led impact investing and the potential outcomes of the next generation AI. Plus new opportunities for language learners and the latest trends and activities in the EdTech space. Contributions from Benjamin Vedrenne-Cloquet, CEO and Co-Founder ImpactX2050 & EdtechX & Operating Partner at IBIS Capital and Memrise co-founders, Steve Toy and Ben Whately.
Read the January edition here.
In this month's X Report, Brighteye Ventures share findings on 'Learning for the over 50s' and the opportunity this market presents in Europe, and we explore the technology skills gap and market activity within the technology skills sector.
Read the November edition here.
IBIS Capital advises Docquity on Series C fundraise, with ITOCHU Corporation providing investment to fuel growth of doctor network and services to the pharmaceutical industry.
IBIS Capital advises Aventis Media and its shareholders on the sale.
IBIS Capital advises BibliU on Series B fundraise, with OSE and Stonehage Fleming providing investment to fuel expansion and liquidity to shareholders.
IBIS Capital advises Carbon AI on its majority sale.
IBIS Capital advises Virtual College and its shareholders on its 100% sale to Netex (BME:NTX).
Winter Capital, ADQ and ETS Strategic Education Group support the scaling of India’s leading higher education admissions platform.
IBIS Capital advises iheed on majority sale and primary investment to drive scaling within the fast-growing medical education sector.
Regulated by the Financial Conduct Authority.
Copyright © 2022 IBIS Capital Limited. All Rights Reserved.
